Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Semaglutide is a GLP-1 receptor agonist that mimics the natural GLP-1 hormone produced in the small intestine
According to FDA-approved labeling and clinical trial data, the following side effects occur most commonly: Gastrointestinal Effects: Nausea (affecting 1544% of patients, with higher rates at Wegovy doses) [3] [4] Diarrhea (reported in 830% of patients) Vomiting (524% incidence) Constipation (occurring in 324% of patients) Abdominal pain (520% of patients) These gastrointestinal symptoms typically emerge during dose escalation and often diminish with continued therapy as physiological adaptation occurs
Three Paths Forward When you reach goal weight on Semaglutide , three options are on the table
There is also a longevity fervor now, with longevity clinics, longevity companies (recently reviewed here), and longevity doctors
